General MedicationsINJECTIONStandard
ADUHELM
ADUCANUMAB-AVWA
Standard Dose
170MG/1.7ML (100MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview ADUHELM is listed in Drugs@FDA under application 761178 (BLA).
Review priority: N/A Marketing status: Prescription Active ingredient ADUCANUMAB-AVWA Form and strength INJECTABLE;INJECTION - 170MG/1.7ML (100MG/ML) Sponsor BIOGEN INC Submission history Latest submission status date: 2024-03-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview ADUHELM is listed in Drugs@FDA under application 761178 (BLA). Review priority: N/A Marketing status: Prescription Active ingredient ADUCANUMAB-AVWA Form and strength INJECTABLE;INJECTION - 170MG/1.7ML (100MG/ML) Sponsor BIOGEN INC Submission history Latest submission status date: 2024-03-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.